4-hydroxy-1-pyrroline-2-carboxylic acid

Metabolite details

Identifier

AOMLMYXPXUTBQH-UHFFFAOYSA-N

InChI Key

AOMLMYXPXUTBQH-UHFFFAOYSA-N

IUPAC name

3-hydroxy-3,4-dihydro-2H-pyrrole-5-carboxylic acid

Preferred name

4-hydroxy-1-pyrroline-2-carboxylic acid

INN name

—

Synonym

1-Pyrroline-4-hydroxy-2-carboxylate

ChEBI

CHEBI:16352

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Brain metabolomic profiling of eastern honey bee (Apis cerana) infested with the mite Varroa destructor.

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• WT_vs_WT_Aco
• Sham_vs_UIR
• Sham_vs_UIR
• G1_PBS_vs_G2_DSS
• Mite_Infestation_vs_Control
• Mite_Infestation_vs_Control